P21 (P021) Dosing: Studied Regimens (Preclinical)
> Updated:
Calculate the P21 (P021) dose
The calculator is already set up for P21 (P021) — adjust the dose or diluent volume for your vial.
Human dosing
P21 (P021) peptide searches are usually about the specific dose range rather than the mechanism of action, so the figures below collect those numbers from public sources without the status of a clinically validated schedule.
| Period / condition | Dose | Escalation |
|---|---|---|
| Start | 100–250 mcg/day, subcutaneous | Starting dose |
| Typical regimen | 250–500 mcg/day, 4–6 week course | Increase if needed |
| Upper bound cited in protocols | up to ~1000 mcg/day | Maximum in this schedule |
Practical dosing details for P21
No controlled human clinical data exist for P21: only preclinical rodent studies and scattered protocols from public sources are available. So the schedule on this page (100–250 mcg to start, 250–500 mcg as the typical regimen, up to ~1000 mcg as the upper bound) is a summary of the ranges described in those sources, not the result of a controlled dose-finding trial.
Oral dosing in feed and subcutaneous injection are not interchangeable routes: peptides generally have lower oral bioavailability, so doses described for rodents on feed cannot be carried over directly to subcutaneous human-adjacent protocols without recalculating.
The gradual increase in these protocols follows the usual logic for a new research peptide: start at the lower bound, assess tolerability over a few weeks, and only then move to the upper range, rather than starting at the highest described dose.
This is reference information for planning a research protocol, not a medical recommendation and not instructions for self-administration.
How to reconstitute
An example reconstitution for convenient dosing. The exact ratios depend on your vial. For research reference only — not medical guidance.
- 1Add the diluentUse bacteriostatic water. Example: 2 ml into a 10 mg vial.P21 (P021)10 mg+ 2 mlDiluent
- 2Get the concentrationExample: 10 mg in 2 ml =P21 (P021)5 mg/ml(5,000 mcg/ml)
- 3Work out the volume per doseFor example, for a 0.1 mg dose:0.1 mg = 0.02 ml= 2 u. (U-100)
This is only an example calculation. You can use a different diluent volume — plug your own numbers into the calculator. Open calculator →
Research protocols
P21: reference regimens
Controlled data on this compound are limited.
P21 (P021) is a derivative of the active region of CNTF; it has been studied mainly preclinically (rodents, oral in feed), while research protocols usually administer it subcutaneously (less often intranasally).
More scientific background in the P21 (P021) monograph
Notes and safety
- • P21 (P021) is a research peptide. Human safety and efficacy data are limited.
- • The regimens shown are based on publications and research protocols, not clinical recommendations.
- • Individual reactions may vary. Published protocols typically start dosing at the lower end of the reported range.
- • Not recommended for use with chronic illness, pregnancy, or breastfeeding.
- • This information is for educational purposes and is not medical advice.
P21 (P021)